{{cart_num}}
My CartCAS：145040-37-5
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 145040-37-5 |
| Name | Candesartan Cilexetil |
| Molecular Formula | C33H34N6O6 |
| Molecular Weight | 610.66 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 627-030-2 |
| MDL | MFCD00871371 |
| SMILES | O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)=CC=C1)OC(OC(OC6CCCCC6)=O)C |
| InChIKey | GHOSNRCGJFBJIB-UHFFFAOYSA-N |
| InChI | InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38) |
| PubChem CID | 2540 |
| Target Point | Angiotensin Receptor |
| Passage | GPCR & G Protein |
| Background | It is a specific, non-peptide angiopoietin II receptor (ATR) antagonist. |
| Biological Activity | Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension[1]. |
| In Vivo | In rats，TCV-116 inhibited the pressor responses to Ang I，Ang II，and Ang III without an effect on the bradykinin(BK)-induced depressor response. In SHR，the antihypertensive effect of TCV-116(10 mg/kg)was larger than the maximum antihypertensive effect of enalapril and was not intensified by combination with enalapril. TCV-116 is more effective than enalapril in reducing blood pressure in SHR and 1K，1C-HR，and that the BK- and/or prostaglandin-potentiating effect of enalapril contributes little to its antihypertensive mechanism in SHR [2]. |
| Data Literature Source | [1]. Pfeffer，M.A.，et al.，Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet，2003. 362(9386): p. 759-66. [2]. Wada，T.，et al.，Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. Hypertens Res，1996. 19(2): p. 75-81. |
| Unit | Bottle |
| Specification | 500mg 1g |
一种特异性的，非肽类血管生成素II受体（ATR）拮抗剂。
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Manual Download
